SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA.

Iovance Biotherapeutics Inc

Iovance Biotherapeutics is surging on heavy volume as investors speculate that significant news or institutional accumulation is underway, with the community actively discussing the potential for a short squeeze and long-term breakthroughs in oncology. Sentiment remains bullish as stakeholders closely monitor institutional interest and upcoming catalysts, viewing current activity as a potential pivot point toward higher valuation levels.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services. The company was founded in April 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending as investors debate whether the stock's recent volatility is a short-term manipulation or a setup for a breakout, with community sentiment divided between frustration over dilution and optimism fueled by rising institutional ownership. The ongoing discussion centers on upcoming earnings as a potential catalyst, while traders closely watch whether key support levels can hold against perceived algorithmic selling pressure.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors and the public react to the company's new initiative to sell high-speed, premium access to platform posts, alongside ongoing discourse surrounding the former president's recent political commentary. Community discussion remains heavily polarized, with active debates concerning the stock's financial viability, the implications of new revenue models, and broader political controversies influencing market sentiment.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as investors react to the companys recent operational updates and preparation for the ASCO meeting, with the community actively debating the timing of trial results, potential partnership developments, and the recent delay in regulatory filings.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is currently navigating significant volatility as investors weigh the company's strong contracted revenue pipeline against a broader rotation out of AI infrastructure stocks. The community is actively debating whether the recent deep price correction represents a prime buying opportunity or a signal of deeper institutional caution ahead of upcoming earnings.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake is trending as investors reassess the company's long-term growth potential following the unveiling of a performance-based CEO compensation package tied to ambitious market cap targets. While some community members remain skeptical of the stock's valuation and ongoing competitive pressures, the consensus focus remains on Snowflake's ability to capitalize on enterprise demand for AI-driven data infrastructure and cloud growth.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is generating strong community interest ahead of a major data presentation at the AHNS conference, with investors closely watching the potential synergistic impact of their Alpha DaRT treatment combined with Merck's Keytruda. The stock is currently being driven by a combination of positive clinical trial milestones, recent institutional endorsements, and a growing consensus that the company's oncology platform is significantly undervalued relative to its upcoming catalysts.

Bonk is a dog-themed memecoin on the Solana blockchain, launched on Christmas Day 2022 to revitalize the Solana community following the FTX collapse. Created by an anonymous team of 22 Solana developers and builders, Bonk distributed 50% of its total 100 trillion token supply via airdrop to community members including NFT collectors, developers, and artists.   The project positions itself as "the first Solana dog coin for the people, by the people," explicitly rejecting venture capital backing in favor of grassroots community ownership. What sets Bonk apart from other memecoins is its combination of fair launch mechanics, extensive ecosystem integration, and active deflationary strategy.   Built on Solana, BONK benefits from fast transaction speeds and low fees that make it practical for everyday use. Native products include LetsBonk.fun (a memecoin launchpad that briefly became Solana's market leader in 2025, surpassing Pump.fun with over 78% market share), BonkSwap (a decentralized exchange) and BonkBot (a Telegram trading bot with built-in burn mechanics).   BONK is available across 10 blockchain networks and listed on major exchanges including Binance, Coinbase, Kraken, and Robinhood. Governance is handled by BonkDAO, which holds 15% of the token supply and makes decisions through on-chain voting.   The community has organized several major burn events, most notably the December 2024 BURNmas campaign that destroyed 1.69 trillion tokens worth over $50 million. In September 2025, Nasdaq-listed Safety Shot, Inc. formed BONK Holdings LLC and acquired over 2.5% of the circulating supply (valued at $55-63 million), making BONK one of the first memecoins to attract formal corporate treasury adoption. Core contributor Nom was appointed to Safety Shot's board, and the company holds a 10% revenue share in LetsBonk.fun.  As with all memecoins, BONK is a highly speculative asset with substantial volatility. Its value is primarily driven by community sentiment, social media momentum, and meme culture rather than traditional utility.   The anonymous team, while common in the memecoin space, means investors should exercise appropriate caution. Despite these risks, Bonk has established itself as one of the most successful community-driven tokens in the Solana ecosystem, approaching 1 million unique holders and expanding from a simple memecoin into meaningful DeFi infrastructure.

BONK

BONK is currently driving intense debate as investors weigh accusations of it being a scam against optimistic community sentiment driven by broader memecoin market volatility. While some participants are actively accumulating the token in anticipation of a potential bull run, others remain deeply skeptical and are calling for caution amidst concerns about its long-term viability.

Federal National Mortgage Association is a government-sponsored company, which engages in the provision of liquidity for purchases of homes and financing of multifamily rental housing and refinancing existing mortgages. It operates through the Single-Family and Multifamily segments. The Single-Family segment offers liquidity to the mortgage market and increases the availability and affordability of housing for single families. The Multifamily segment includes guaranty fees on mortgages and on multifamily mortgage loans. The company was founded in 1938 and is headquartered in Washington, DC.

Federal National Mortgage Association

FNMA is experiencing high volatility and increased retail interest following presidential comments valuing the combined Fannie Mae and Freddie Mac entities at over $1 trillion. While investors are actively debating the potential for an IPO and a release from government conservatorship, community sentiment remains split between long-term optimism regarding a massive valuation shift and frustration over the lack of concrete timelines or actionable reform.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is generating significant buzz as investors weigh the company's recent operational milestones and cash flow performance against ongoing industry-wide volatility. The community is actively debating the stock's future, with many pointing to long-term growth potential and increasing lithium demand as key reasons to maintain their positions despite recent price fluctuations.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

GLSI Stock Climbs After Removing A Key Overhang – Retail Turns Focus To High-Stakes Breast Cancer Trial

Equity

Greenwich LifeSciences said the delay in filing Form 10-K was due to accounting adjustments tied to stronger-than-expected patient enrollment in its Phase III trial to treat breast cancer.

Greenwich LifeSciences (NASDAQ:GLSI) Cut to "Sell" at Wall Street Zen

Wall Street Zen lowered shares of Greenwich LifeSciences from a "hold" rating to a "sell" rating in a research note on Saturday...

HC Wainwright Has Bearish Estimate for GLSI FY2026 Earnings

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Research analysts at HC Wainwright dropped their FY2026 EPS estimates for shares of Greenwich LifeSciences in a research report issued on...

Why Did GLSI Stock Rise Pre-Market Today?  

The company unveiled new Phase 3 data suggesting its breast cancer vaccine candidate could work across a broader patient population than initially targeted


Greenwich LifeSciences (GLSI) Expected to Announce Earnings on Tuesday

Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, April 21. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-4-21-greenwich-lifesciences-inc-stock...

Greenwich LifeSciences (GLSI) Expected to Announce Quarterly Earnings on Tuesday

Greenwich LifeSciences (NASDAQ:GLSI) will be releasing earnings after the market closes on Tuesday, March 31. (View Earnings Report at...

Why Is GLSI Stock Rising Today?

Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate of under 1% per year.

Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6% - Should You Buy?

Greenwich LifeSciences (NASDAQ:GLSI) Trading Up 11.6% - Time to Buy...

Greenwich LifeSciences, Inc. (NASDAQ:GLSI) Short Interest Down 14.7% in January

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Get Free Report) was the target of a significant drop in short interest in January. As of January 30th, there was short interest totaling 1,318,481 shares...

HC Wainwright Issues Positive Forecast for GLSI Earnings

Greenwich LifeSciences, Inc. (NASDAQ:GLSI - Free Report) - Stock analysts at HC Wainwright upped their Q3 2026 earnings per share estimates for Greenwich LifeSciences in a report released on...

Bullish Sentiment

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is pacing for a losing week as a semiconductor ($SMH) sell-off has dragged the market lower amid growing doubts about AI spending. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Stocktwits

Stocktwits Polls

Investors are closely tracking European regulatory approval to combine HLA populations, viewing it as a pivotal step to accelerate trial enrollment and potential outcomes.

Discussions center on the potential for an early interim analysis to prove efficacy, with speculation about how upcoming trial data could trigger a major price breakout.

Traders are monitoring high borrow rates and short interest, betting that forced covering could spark a violent, rapid move to the upside.

Advocates argue the unique trial design and massive site footprint make this a prime acquisition target for Big Pharma upon reaching key clinical milestones.

Current Price	$16.32
Prev Close	$19.01
Open	$18.56
Dividend Yield	0.00%
50-Day Moving Average	$23.39
Beta	1.57
Avg. Volume	167,983.19
PE Ratio	-12.28

52-Week High	$34.10
52-Week Low	$7.78
Market Capitalization	$279.03M
EPS (Annual)	-$1.43
Price to Book	52.90
Revenue Per Employee	$0.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

GLSIGreenwich LifeSciences Inc

Latest GLSI News